DAUNORUBICIN + CYTARABINE

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial

DAUNORUBICIN + CYTARABINE (14672F)

daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial
14672F
Body System:
Manner of administration:Injection
Private
Chemotherapy Items for Private Hospital use
Authority Required

Restriction

Indication: Acute Myeloid Leukaemia
Treatment phase: Consolidation therapy
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 64 mg # of repeats: 3 DPMA: $16,796.92 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vyxeos
(daunorubicin hydrochloride 44 mg + cytarabine 100 mg injection, 1 vial)